Skip to main content
Erschienen in: Journal of General Internal Medicine 5/2007

01.05.2007 | Original Article

What are the Essential Elements to Enable Patient Participation in Medical Decision Making?

verfasst von: Liana Fraenkel, MD, MPH, Sarah McGraw, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Patient participation in shared decision making (SDM) results in increased patient knowledge, adherence, and improved outcomes. Despite the benefits of the SDM model, many patients do not attain the level of participation they desire.

OBJECTIVE

To gain a more complete understanding of the essential elements, or the prerequisites, critical to active patient participation in medical decision making from the patient’s perspective.

DESIGN

Qualitative study.

SETTING

Individual, in-depth patient interviews were conducted until thematic saturation was reached. Two analysts independently read the transcripts and jointly developed a list of codes.

PATIENTS

Twenty-six consecutive subjects drawn from community dwelling subjects undergoing bone density measurements.

MEASUREMENTS

Respondents’ experiences and beliefs related to patient participation in SDM.

RESULTS

Five elements were repeatedly described by respondents as being essential to enable patient participation in medical decision making: (1) patient knowledge, (2) explicit encouragement of patient participation by physicians, (3) appreciation of the patient’s responsibility/rights to play an active role in decision making, (4) awareness of choice, and (5) time.

LIMITATIONS

The generalizability of the results is limited by the homogeneity of the study sample.

CONCLUSIONS

Our findings have important clinical implications and suggest that several needs must be met before patients can become active participants in decisions related to their health care. These needs include ensuring that patients (1) appreciate that there is uncertainty in medicine and “buy in” to the importance of active patient participation in decisions related to their health care, (2) understand the trade-offs related to available options, and (3) have the opportunity to discuss these options with their physician to arrive at a decision concordant with their values.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med. 2003;140:54–9. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med. 2003;140:54–9.
2.
Zurück zum Zitat Kassirer JP. Incorporating patients’ preferences into medical decisions. N Engl J Med. 1994;330:1895–6.PubMedCrossRef Kassirer JP. Incorporating patients’ preferences into medical decisions. N Engl J Med. 1994;330:1895–6.PubMedCrossRef
3.
Zurück zum Zitat Greenfield S, Kaplan S, Ware JE, Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med. 1985;102:520–8.PubMed Greenfield S, Kaplan S, Ware JE, Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med. 1985;102:520–8.PubMed
4.
Zurück zum Zitat Kennedy AD, Sculpher MJ, Coulter A, et al. Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. JAMA. 2002;288:2701–8.PubMedCrossRef Kennedy AD, Sculpher MJ, Coulter A, et al. Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. JAMA. 2002;288:2701–8.PubMedCrossRef
5.
Zurück zum Zitat Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ. 2002;324:91–4.PubMedCrossRef Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ. 2002;324:91–4.PubMedCrossRef
6.
Zurück zum Zitat van Dam HA, van der Horst F, van den Borne B, Ryckman R, Crebolder H. Provider–patient interaction in diabetes care: effects on patients self-care and outcomes. Patient Educ Couns. 2003;51:17–28.PubMedCrossRef van Dam HA, van der Horst F, van den Borne B, Ryckman R, Crebolder H. Provider–patient interaction in diabetes care: effects on patients self-care and outcomes. Patient Educ Couns. 2003;51:17–28.PubMedCrossRef
7.
Zurück zum Zitat Ward MM, Sundaramurthy S, Lotstein D, Bush TM, Neuwelt CM, Street RJ. Participatory patient–physician communication and morbidity in patients with systemic lupus erythematosus. Arthritis Rheum. 2003;49:810–18.PubMedCrossRef Ward MM, Sundaramurthy S, Lotstein D, Bush TM, Neuwelt CM, Street RJ. Participatory patient–physician communication and morbidity in patients with systemic lupus erythematosus. Arthritis Rheum. 2003;49:810–18.PubMedCrossRef
8.
Zurück zum Zitat Street RL, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making. 1997;17:298–306.PubMedCrossRef Street RL, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making. 1997;17:298–306.PubMedCrossRef
9.
Zurück zum Zitat Souchek J, Stacks JR, Brody B, et al. A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visit. Med Care. 2000;38:1040–50.PubMedCrossRef Souchek J, Stacks JR, Brody B, et al. A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visit. Med Care. 2000;38:1040–50.PubMedCrossRef
10.
Zurück zum Zitat Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med. 2001;52:1865–78.PubMedCrossRef Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med. 2001;52:1865–78.PubMedCrossRef
11.
Zurück zum Zitat Bilodeau BA, Degner LF. Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum. 1996;23:691–6.PubMed Bilodeau BA, Degner LF. Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum. 1996;23:691–6.PubMed
12.
Zurück zum Zitat Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485–92.PubMedCrossRef Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485–92.PubMedCrossRef
13.
Zurück zum Zitat Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC. Treatment decision making in early-stage breast cancer: should surgeons match patients’ desired level of involvement. J Clin Oncol. 2002;20:1473–9.PubMedCrossRef Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC. Treatment decision making in early-stage breast cancer: should surgeons match patients’ desired level of involvement. J Clin Oncol. 2002;20:1473–9.PubMedCrossRef
14.
Zurück zum Zitat Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Tritchler DL, Till JE. Cancer patients: their desire for information and participation in treatment decisions. J R Soc Med. 1989;82:260–3.PubMed Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Tritchler DL, Till JE. Cancer patients: their desire for information and participation in treatment decisions. J R Soc Med. 1989;82:260–3.PubMed
15.
Zurück zum Zitat Caress AL. Patient roles in decision-making. Nurs Times. 1997;93:45–8.PubMed Caress AL. Patient roles in decision-making. Nurs Times. 1997;93:45–8.PubMed
16.
Zurück zum Zitat Levinson W, Kao A, Kuby A, Thisted RA. Not all patients want to participate in decision-making. J Gen Intern Med. 2005;20:531–5.PubMedCrossRef Levinson W, Kao A, Kuby A, Thisted RA. Not all patients want to participate in decision-making. J Gen Intern Med. 2005;20:531–5.PubMedCrossRef
17.
Zurück zum Zitat Say RE, Thomson R. The importance of patient preferences in treatment decisions-challenges for doctors. BMJ. 2003;327:542–5.PubMedCrossRef Say RE, Thomson R. The importance of patient preferences in treatment decisions-challenges for doctors. BMJ. 2003;327:542–5.PubMedCrossRef
18.
Zurück zum Zitat Street RL, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005;43:960–9.PubMedCrossRef Street RL, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005;43:960–9.PubMedCrossRef
19.
Zurück zum Zitat Fraenkel L, Gulanski B, Wittink DR. Patient treatment preferences for osteoporosis. Arthritis Rheum. 2006;55(5):729–35.PubMedCrossRef Fraenkel L, Gulanski B, Wittink DR. Patient treatment preferences for osteoporosis. Arthritis Rheum. 2006;55(5):729–35.PubMedCrossRef
20.
Zurück zum Zitat Krueger RA. Focus Groups: A Practical Guide for Applied Research. Thousand Oaks, CA: Sage Publications; 1994. Krueger RA. Focus Groups: A Practical Guide for Applied Research. Thousand Oaks, CA: Sage Publications; 1994.
21.
Zurück zum Zitat Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. New York: Aldine Publishing Company; 1967. Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. New York: Aldine Publishing Company; 1967.
22.
Zurück zum Zitat Miles M, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage Publications; 1994. Miles M, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage Publications; 1994.
23.
Zurück zum Zitat Weitzman EA. Software and qualitative research. In: Denzin N, Lincoln Y, eds. Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications; 1999. Weitzman EA. Software and qualitative research. In: Denzin N, Lincoln Y, eds. Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications; 1999.
24.
Zurück zum Zitat Kraetschmer N, Sharpe N, Urowitz S, Deber RB. How does trust affect patient preferences for participation in decision-making? Health Expect. 2004;7:317–26.PubMedCrossRef Kraetschmer N, Sharpe N, Urowitz S, Deber RB. How does trust affect patient preferences for participation in decision-making? Health Expect. 2004;7:317–26.PubMedCrossRef
25.
Zurück zum Zitat McNutt RA. Shared medical decision making: problems, process, progress. JAMA. 2004;292:2516–18.PubMedCrossRef McNutt RA. Shared medical decision making: problems, process, progress. JAMA. 2004;292:2516–18.PubMedCrossRef
26.
Zurück zum Zitat O’Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003:CD001431. O’Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003:CD001431.
Metadaten
Titel
What are the Essential Elements to Enable Patient Participation in Medical Decision Making?
verfasst von
Liana Fraenkel, MD, MPH
Sarah McGraw, PhD
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 5/2007
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0149-9

Weitere Artikel der Ausgabe 5/2007

Journal of General Internal Medicine 5/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.